Inventor · disambiguated record
Katrina W. Lexa
Also filed as: LEXA KATRINA W
4 granted patents·16 pending applications·6 citations·filing 2018–2025
66Inventor score
Top patents by PatentIndex Score
20 records- 0189US11643446B2Progranulin variantsDENALI THERAPEUTICS INC·Filed 2022·Granted May 9, 2023·4 cites·50 claims
- 0280US11236100B2Modulators of eukaryotic initiation factor 2B, compositions and methodsDENALI THERAPEUTICS INC·Filed 2018·Granted Feb 1, 2022·1 cites·30 claims
- 0379US2024140919A1Modulators of eukaryotic initiation factor 2DENALI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0476US2023250072A1Modulators of eukaryotic initiation factor 2DENALI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0575US11851440B2Modulators of eukaryotic initiation factor 2B, compositions and methodsDENALI THERAPEUTICS INC·Filed 2021·Granted Dec 26, 2023·0 cites·18 claims
- 0674US2023265137A1Progranulin variantsDENALI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0773US12139478B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2018·Granted Nov 12, 2024·1 cites·57 claims
- 0869US2022220172A1Progranulin variantsDENALI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0965US2025388595A1Modulators of eukaryotic initiation factor 2b, compositions and methodsDENALI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1064US2021188925A1Progranulin variantsDENALI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1164US2021130308A1Modulators of eukaryotic initiation factor 2DENALI THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1261US2025361234A1Compounds, compositions, and methodsNICO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1359US2025171462A1Compounds, compositions, and methodsNICO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1459US2025145592A1Compounds, compositions, and methodsNICO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1559US2025197399A1Compounds, compositions, and methodsTENVIE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1658US2024254132A1Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1754US2023357162A1Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1853US2023348437A1Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1953US2023416205A1Compounds, compositions, and methodsDENALI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2049US2022177456A1Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Katrina W. Lexa files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →